A prognostic index for ductal carcinoma in situ of the breast

Cancer

Volumn 77, Issue 11, 1996, Pages 2267-2274

  Silverstein, Melvin J ^a   Lagios, Michael D ^b,c   Craig, Pamela H ^a   Waisman, James R ^a   Lewinsky, Bernard S ^a   Colburn, William J ^a   Poller, David N ^d  

^a The Breast Center Inc   (United States)

^b ST MARY S MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

breast ductal carcinoma in situ (DCIS); intraductal breast cancer; minimal breast carcinoma; noninvasive breast carcinoma; prognostic index

Indexed keywords

ARTICLE; BREAST SURGERY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SCORING SYSTEM; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIFE TABLES; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0029956048     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V     Document Type: Article

References (31)

1. Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63:731-41.
2. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 1994; 73:118-24.
3. Silverstein MJ. Intraductal breast carcinoma: two decades of progress? Am J Clin Oncol 1991; 14(6):534-7.
4. Ashikari R, Hadju SI, Robbins GF. Intraductal carcinoma of the breast. Cancer 1971; 28:1182-7.
5. Fentiman IS, Fagg N, Millis RR, Hayward JL. In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol 1986; 12:261-6.
6. Bradley SJ, Weaver DW, Bouwman DL. Alternative in the surgical management of in situ breast cancer. Am Surg 1990; 56:428-32.
7. Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Noninvasive breast carcinoma. Results of a national survey of The American College of Surgeons. Ann Surg 1980; 192:139-47.
8. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995; 31:1425-7.
9. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50:1309-14.
10. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 1990; 70:853-71.
11. Solin LJ, Recht A, Fourquet A, Kurtz J, Kuske R, McNeese M, et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma of the breast. Cancer 1991; 68:2337-44.
12. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. Am J Surg Pathol 1992; 16:1183-96.
13. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 1992; 70:2468-74.
14. Solin LJ, Yeh I, Kurtz J, Fourquet A, Recht A, Kuske R, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Cancer 1993; 71:2532-42.
15. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast duct carcinoma in situ. Lancet 1995; 345:1154-7.
16. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991; 21:289-92.
17. Kuske RR, Bean JM, Garcia DM, Perez CA, Andriole D, Philpott G, et al. Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 1993; 26:391-6.
18. Bornstein BA, Recht A, Connolly JL, Schnitt SJ, Cady B, Koufman C, et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 1991; 67:7-13.
19. Fisher B, Constantino J, Redmond C, Fisher ER, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl JMed 1993; 328:1581-6.
20. Lagios MD, Page DL. Radiation therapy for in situ or localized breast cancer [letter]. N Engl J Med 1993; 21:1577-8.
21. Page DL, Lagios MD. Pathologic analysis of the NSABP-B17 Trial. Cancer 1995; 75:1219-22.
22. Bellamy COC, McDonald D, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993; 24:16-23.
23. Zafrani B, Leroyer A, Fourquet A, Laurent M, Trophilme D, Validire P, et al. Mammographically detected ductal carcinoma in situ of the breast analysed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins and proliferative activity. Semin Diagn Pathol 1994; 11(3):208-13.
24. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63:618-24.
25. Lagios MD. Ductal carcinoma in situ: controversies in diagnosis, biology, and treatment. Breast J 1995; 1:68-78.
26. Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blarney RW, et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994; 7:257-62.
27. Fisher ER, Constantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Cancer 1995; 75:1310-9.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
29. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-70.
30. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972; 34:187-220.
31. Solin LJ, Fourquet A, McCormick B, Haffty B, Recht A, Schultz DJ, et al. Salvage treatment for local recurrence following breast conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys 1994; 30:3-9.